相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。On the use of corticosteroids for 2019-nCoV pneumonia
Lianhan Shang et al.
LANCET (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Jasper Fuk-Woo Chan et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
COVID-19: combining antiviral and anti-inflammatory treatments
Justin Stebbing et al.
LANCET INFECTIOUS DISEASES (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization
Lina Chen et al.
PLOS ONE (2020)
Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
Achille Aouba et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
Omer Gendelman et al.
AUTOIMMUNITY REVIEWS (2020)
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
Jaume Alijotas-Reig et al.
AUTOIMMUNITY REVIEWS (2020)
Convalescent plasma in Covid-19: Possible mechanisms of action
Manuel Rojas et al.
AUTOIMMUNITY REVIEWS (2020)
COVID-19 infection: the perspectives on immune responses
Yufang Shi et al.
CELL DEATH AND DIFFERENTIATION (2020)
Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
George Dimopoulos et al.
CELL HOST & MICROBE (2020)
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Wen Zhang et al.
CLINICAL IMMUNOLOGY (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Colchicine may not be effective in COVID-19 infection; it may even be harmful?
Medine Cumhur Cure et al.
CLINICAL RHEUMATOLOGY (2020)
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
Waleed Alhazzani et al.
CRITICAL CARE MEDICINE (2020)
Cytokine storm intervention in the early stages of COVID-19 pneumonia
Xinjuan Sun et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
Jesus Villar et al.
LANCET RESPIRATORY MEDICINE (2020)
Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports
Valeria Gaspari et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
Zahra Sahraei et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1)pdm09 infection complications and rapidity of symptoms relief
Azfar Athar Ishaqui et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)
Convalescent Plasma to Treat COVID-19 Possibilities and Challenges
John D. Roback et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
Dan Zhou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
Fabrizio Cantini et al.
JOURNAL OF INFECTION (2020)
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
Yun Xie et al.
JOURNAL OF INFECTION (2020)
Tocilizumab treatment in COVID-19: A single center experience
Pan Luo et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?
Pierre Tiberghien et al.
VOX SANGUINIS (2020)
Covid-19: what treatments are being investigated?
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Interferon-α2b Treatment for COVID-19
Qiong Zhou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Yonggang Zhou et al.
NATIONAL SCIENCE REVIEW (2020)
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
Wei Cao et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19
Harmony R. Reynolds et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Considerations for Statin Therapy in Patients with COVID-19
Simin Dashti-Khavidaki et al.
PHARMACOTHERAPY (2020)
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!
Alan A. Nguyen et al.
CLINICAL IMMUNOLOGY (2020)
Type 1 interferons as a potential treatment against COVID-19
Erwan Sallard et al.
ANTIVIRAL RESEARCH (2020)
Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine
Srinivasa Reddy Bonam et al.
AUTOPHAGY (2020)
Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19
Gregory Curfman
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Yhojan Rodriguez et al.
JOURNAL OF AUTOIMMUNITY (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
Lang Wang et al.
JOURNAL OF INFECTION (2020)
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection
Anuradha Lala et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
Anton De Spiegeleer et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
A single center observational study lb Check of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia
Federico Alberici et al.
KIDNEY INTERNATIONAL (2020)
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
John R. Giudicessi et al.
MAYO CLINIC PROCEEDINGS (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID-19
Sarah C. J. Jorgensen et al.
PHARMACOTHERAPY (2020)
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
Dennis McGonagle et al.
LANCET RHEUMATOLOGY (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
Srinivasa Reddy Bonam et al.
CELL REPORTS MEDICINE (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
Luke Adam Monteagudo et al.
ACR OPEN RHEUMATOLOGY (2020)
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
Eakachai Prompetchara et al.
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY (2020)
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
[Anonymous]
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE (2020)
Broad-spectrum coronavirus antiviral drug discovery
Allison L. Totura et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Macrolides in critically ill patients with Middle East Respiratory Syndrome
Yaseen M. Arabi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Emerging Therapies in the Treatment of Early Childhood Wheeze
Elissa M. Abrams et al.
PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY (2019)
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib
Elena Maria Elli et al.
FRONTIERS IN ONCOLOGY (2019)
Azithromycin suppresses Th1-and Th2-related chemokines IP-10/MDC in human monocytic cell line
Chang-Hung Kuo et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2019)
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Yaseen M. Arabi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Adjunctive therapy with azithromycin for moderate and severe acute respiratory distress syndrome: a retrospective, propensity score-matching analysis of prospectively collected data at a single center
Kodai Kawamura et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Group 2 innate Lymphoid Cells in Pulmonary immunity and Tissue Homeostasis
Barbara C. Mindt et al.
FRONTIERS IN IMMUNOLOGY (2018)
IVIG-mediated effector functions in autoimmune and inflammatory diseases
Caroline Galeotti et al.
INTERNATIONAL IMMUNOLOGY (2017)
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
Sara Trabanelli et al.
NATURE COMMUNICATIONS (2017)
Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial
Nelson Lee et al.
ANTIVIRAL RESEARCH (2017)
Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives
Maciej Kupczyk et al.
DRUGS (2017)
A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension
Mathieu Hylands et al.
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2017)
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
Farhad Seif et al.
CELL COMMUNICATION AND SIGNALING (2017)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Corticosteroids as adjunctive therapy in the treatment of influenza
Chamira Rodrigo et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
The relative balance of GM-CSF and TGF-β1 regulates lung epithelial barrier function
Christian E. Overgaard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies
Grant S. Schulert et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Angiotensin II in inflammation, immunity and rheumatoid arthritis
Y. Chang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Colchicine as an anti-inflammatory and cardioprotective agent
Armen Yuri Gasparyan et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
Palash Bhattacharya et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
Shu Yuan
MBIO (2015)
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
Allison L. Totura et al.
MBIO (2015)
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
Yaseen Arabi et al.
SPRINGERPLUS (2015)
Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells
Aline Schogler et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Inhaled Granulocyte/Macrophage Colony-Stimulating Factor as Treatment of Pneumonia-associated Acute Respiratory Distress Syndrome
Susanne Herold et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway
Xiao Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Inhibition of NF-κB-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
Marta L. DeDiego et al.
JOURNAL OF VIROLOGY (2014)
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
Ali S. Omrani et al.
LANCET INFECTIOUS DISEASES (2014)
The immunomodulatory effects of statins in community-acquired pneumonia: A systematic review
D. P. R. Troeman et al.
JOURNAL OF INFECTION (2013)
Tocilizumab - A novel therapy for non-organ-specific autoimmune diseases
Lisa Kaly et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2012)
Hydroxychloroquine: From Malaria to Autoimmunity
Ilan Ben-Zvi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury
Robert Paine et al.
CRITICAL CARE MEDICINE (2012)
Azithromycin and the Risk of Cardiovascular Death
Charles A. Knirsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Azithromycin and the Risk of Cardiovascular Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2011)
Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease
Chris Tikellis et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2011)
Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice
Jincun Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Immunomodulation in the critically ill
N. R. Webster et al.
BRITISH JOURNAL OF ANAESTHESIA (2009)
Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains
Jesus F. Bermejo-Martin et al.
Journal of Infection in Developing Countries (2009)
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans
Carmela De Santo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry
Shiori Haga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
Timothy Sheahan et al.
PLOS PATHOGENS (2008)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Y Imai et al.
NATURE (2005)
Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome
KHL Ng et al.
POSTGRADUATE MEDICAL JOURNAL (2005)
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
CK Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients
YOY Soo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Inflammation, immunity, and HMG-CoA reductase inhibitors -: Statins as antiinflammatory agents?
U Schönbeck et al.
CIRCULATION (2004)
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome - A preliminary study
MR Loutfy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction
JJ Presneill et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Glucocorticoids and inflammation revisited: The state of the art
D Franchimont et al.
NEUROIMMUNOMODULATION (2002)
Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome
G Matute-Bello et al.
CRITICAL CARE MEDICINE (2000)
分享论文
